…..Ayo TCM Consultant
Malaria remains one of the most devastating infectious diseases in the world, caused by the Plasmodium parasite and transmitted through the bite of infected female Anopheles mosquitoes. According to the World Health Organization (WHO, 2023), malaria caused an estimated 249 million cases and over 608,000 deaths globally in 2022, with Africa bearing more than 94% of the burden. In Nigeria alone, malaria accounts for about 31% of global cases and 26% of global malaria deaths, making it a national public health emergency.
As a healthcare consultant with substantial experience in malaria treatment across Nigeria and other developing countries, I have seen the increasing challenge of drug resistance in malaria treatment, and the urgent need for effective, sustainable, and safer solutions like Qinghao (Artemisia annua), a flagship natural product of Kedi Healthcare produced in collaboration with leading pharmaceutical partners.
The Plasmodium Parasite: How Malaria Spreads
The Plasmodium parasite is a microscopic organism that infects red blood cells. Of the five Plasmodium species that infect humans, Plasmodium falciparum is the deadliest and most widespread in Africa.
Transmission process:
- An infected female Anopheles mosquito bites a person.
- The parasite enters the bloodstream and travels to the liver.
- Within days, it multiplies rapidly and attacks red blood cells.
- This leads to symptoms such as fever, chills, sweating, fatigue, and anemia
The Challenge of Drug Resistance in Malaria
One of the biggest threats to malaria control today is drug resistance. For decades, synthetic antimalarial drugs such as chloroquine, sulfadoxine-pyrimethamine, and even artemisinin-based combinations have faced growing resistance in many parts of Africa and Asia.
- According to the WHO Malaria Threats Map (2023), resistance to artemisinin-based combination therapies (ACTs) has already been confirmed in Southeast Asia and is increasingly being reported in Africa.
- In Nigeria, healthcare providers are already reporting cases of delayed parasite clearance, which is an early sign of resistance to current first-line therapies.
- A study published in The Lancet Infectious Diseases (2022) highlighted that without urgent alternatives, Africa could face a malaria resurgence worse than pre-intervention levels.
This situation makes it critical to look into nature-based solutions that have both proven efficacy and reduced resistance risks.
Qinghao: Nature’s Answer to Malaria
QinghQinghao (Artemisia annua), also known as Sweet Wormwood, has been used in Traditional Chinese Medicine (TCM) for over 2,000 years to treat fever and malaria-like symptoms. In 2015, Professor Tu Youyou won the Nobel Prize in Medicine for her discovery of artemisinin, the active compound extracted from Qinghao, which has saved millions of lives globally.
Why Qinghao Stands Out:
- Holistic Support: Beyond parasite clearance, Qinghao helps in reducing inflammation, boosting immunity, and improving recovery.
- Highly Effective: Qinghao contains natural compounds that target the Plasmodium parasite quickly, reducing fever and parasite load.
- Reduced Resistance Risk: Unlike synthetic monotherapies, whole-plant Qinghao extracts offer multiple bioactive compounds, making it harder for the parasite to develop resistance.
Kedi Healthcare’s Qinghao: A Trusted Herbal Solution
Kedi Healthcare, in collaboration with Fidson Pharmaceuticals Nigeria, has developed Qinghao softgel, a standardized herbal formulation that combines ancient Traditional Chinese Medicine knowledge with modern pharmaceutical standards.
Key Benefits of Kedi Qinghao Softgel:
- Provides fast relief from malaria symptoms such as fever, chills, and weakness.
- Acts as a natural antimalarial, targeting parasites effectively.
- Helps strengthen the body’s defense system to prevent recurrence.
Backed by numerous success stories from Nigerian patients and healthcare practitioners.
Success Stories and Growing Acceptance
Across Nigeria, patients who have struggled with repeated malaria episodes due to resistance to synthetic drugs are reporting remarkable results after switching to Kedi Qinghao. Healthcare consultants and herbal practitioners alike are now recommending Qinghao as a first-choice complementary therapy in malaria management.
Conclusion: A Call to Action
The fight against malaria in Nigeria and Africa at large cannot rely solely on synthetic drugs that are losing effectiveness due to resistance. The Plasmodium parasite is evolving, and so must our response.
With Qinghao, Kedi Healthcare offers a proven, natural, and reliable solution that aligns with modern science and traditional wisdom. If you or your loved ones are battling recurrent malaria, it is time to consider Qinghao softgel as part of your health regimen.
For orders and consultations, contact us via WhatsApp: +234 905 302 3466 or visit www.kedihealthformular.com.ng.
Together, we can take a step closer to defeating malaria in Nigeria and across Africa.
